Toronto, ON — February 25, 2026 — Aleen Inc. (CSE: ALEN-U), a digital wellness company, announces continued internal progress in strengthening its Personal Account infrastructure following the previously announced development of...
Read MoreToronto, ON — February 25, 2026 — Aleen Inc. (CSE: ALEN-U), a digital wellness company, announces continued internal progress in strengthening its Personal Account infrastructure following the previously announced development of...
Read MoreToronto, ON — February 10, 2026 — Aleen Inc. (CSE: ALEN-U), a digital wellness company, shares an educational overview of AI agents — what they are, how they function, and why they are becoming an important area of exploration...
Read MoreToronto, ON — January 26, 2026 — Aleen Inc. (CSE: ALEN-U), a digital wellness company, announces the rollout of enhanced navigation features within the Personal Account, its user-facing service for managing wellness information....
Read MoreToronto, ON — January 6, 2026 — Aleen Inc. (CSE: ALEN-U), a digital wellness company, announces that starting in early 2026, it will begin rolling out new features and improvements within the Personal Account, its user-facing...
Read MoreToronto, ON — December 30, 2025 — Aleen Inc. (CSE: ALEN-U), a digital wellness company, reflects on 2025 as a year marked by meaningful growth, product development, and strategic progress in the digital wellness space — all...
Read MoreToronto, ON — December 16, 2025 — Aleen Inc. (CSE: ALEN-U), a digital wellness company, presents a new Insight post focused on the value of noticing how personal wellness patterns evolve over time. The publication highlights why...
Read MoreSAN DIEGO, Dec. 9, 2025 – Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, today announced it has filed an amended registration...
Read MoreLAS VEGAS, NEVADA, December 9, 2025 – Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cellbased therapies for diabetes and age-related disorders,...
Read MoreToronto, ON — December 09, 2025 — Aleen Inc. (CSE: ALEN-U), a digital wellness company, invites users to explore the philosophy behind its Wellness AI platform. From early concept testing to personal insight features, Aleen Inc....
Read MoreToronto, ON — December 02, 2025 — Aleen Inc. (CSE: ALEN-U), a digital wellness company, continues its structured path from early exploration and user testing to personal account development, and now moves into full-scale...
Read MoreKelowna, BC – December 1, 2025 – Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70)(“Doseology” or the “Company”) is pleased to announce the launch of its Investor Communications Initiative, designed to...
Read More